The Venture Codex Logo

The Venture Codex

Overview

Investment group focusing on technology-related companies and startups.

Founded

1999

Deals · 12mo

16

Links

Stage focus

Series A
Series B

Geographic focus

South Korea

Sector focus

Finance
Information Technology
Venture Capital

Investment portfolio

  • Emerald AI

    Participated · Series A · Aug 2026

    Emerald AI, founded in 2024 and based in Washington, D.C., develops energy technology for data centers. The company has raised more than $65 million since its founding and has announced a new $90 million financing round. Emerald AI recently landed a deal with Silicon Valley Power and is preparing to participate in Nvidia's 96-megawatt Manassas data center project. The article does not provide revenue, user, or other operating metrics, nor does it detail the company's specific product architecture. It also does not disclose its investors or valuation in connection with the new financing.

  • Walden Robotics

    Participated · Seed · Jul 2026

    Walden Robotics develops and deploys general-purpose robots powered by Large Behavior Models and other Physical AI advances to perform useful work in manufacturing, logistics, and other industries. Founded in 2026 and launched out of Toyota Research Institute, the company combines foundational robotics research with in-house operations teams to bring robots into production environments. Walden reports that its robots have been operating in production at a Toyota plant in North America since February, progressing from pilot to real work in under two months. The company has strategic partnerships across automotive, aerospace, semiconductors, electronics, logistics, and life sciences and emphasizes human-centered deployment where robots work side-by-side with people. Walden’s stated plans center on scaling commercial deployments and continuous on-the-job learning to improve capabilities over time. Financially, the company announced a $300 million seed round at a $1.1 billion valuation led by Toyota and Deviation Capital, providing capital to support its launch and customer expansion.

  • Alva Industries

    Participated · Equity · Jul 2026

    Alva Industries develops ultra-compact, frameless electric motors using its patented FiberPrinting manufacturing technology to deliver high torque density and cogging-free performance. Headquartered in Trondheim, the company serves customers across robotics, aerospace, defence, medical technology, industrial automation and autonomous systems. Alva reports hundreds of active customer projects across commercial and defence markets and growing demand from OEMs in robotics, aerospace and medical devices. The company manufactures its products in Norway and plans to significantly scale production capacity to meet increasing international demand. The recent equity financing will fund manufacturing expansion, further product development and support its international growth plans.

  • ZutaCore

    Participated · Series C · Jun 2026

    ZutaCore develops a waterless two-phase cooling platform designed to support AI and HPC processors exceeding 4,000 watts. Its technology is deployed in more than 75 installations globally across the Americas, Europe and Asia. The company is scaling commercialisation to meet rising bookings and deployments driven by demand for AI and high-performance computing infrastructure. ZutaCore plans to advance R&D to address next-generation chip thermal requirements and enable integration with air and single-phase cooling systems, as well as support megawatt-class deployments. Following the Series C, it strengthened its leadership team with appointments to COO, chief R&D officer, CFO and chief people officer.

  • Subtle Medical

    Participated · Series C · Jun 2026

    Subtle Medical builds vendor-neutral, AI-powered imaging software designed to operate across existing MRI, PET and CT scanners regardless of manufacturer. Its portfolio includes 11 FDA-cleared software products and its technology is deployed on more than 1,300 scanners globally. The company is developing an AI Imaging Hub intended to help providers manage imaging performance across modalities and scanner fleets. Subtle Medical has been recognized by TIME and by CB Insights on multiple industry lists. Financially, the company has raised a total of $86 million following a $33 million growth financing led by Morgan Stanley Expansion Capital. The company plans to use the new capital to accelerate product development and commercial expansion in the U.S. and international markets.

Insights

Team